-
-
-
-
-
-
-
Alkermes completes $775 million acquisition of Avadel Pharmaceuticals
-
-
-
-
-
-
-
Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”
-
-
-
-
-
-
-
Alkermes plc Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Alkermes to Report Second Quarter Financial Results on July 29, 2025
-
-
-
-
-
-
-
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025
-
-
-
-
-
-
-
Alkermes to Report Second Quarter Financial Results on July 24, 2024
-
-
-
-
-
-
-
Alkermes Completes Separation of Oncology Business
-
1,199,550 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

